{"id":132955,"date":"2017-06-18T05:47:11","date_gmt":"2017-06-18T09:47:11","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/puma-biotechnology-inc-pbyi-receives-buy-rating-from-citigroup-inc-the-cerbat-gem.php"},"modified":"2024-08-17T16:09:40","modified_gmt":"2024-08-17T20:09:40","slug":"puma-biotechnology-inc-pbyi-receives-buy-rating-from-citigroup-inc-the-cerbat-gem","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/puma-biotechnology-inc-pbyi-receives-buy-rating-from-citigroup-inc-the-cerbat-gem.php","title":{"rendered":"Puma Biotechnology Inc (PBYI) Receives Buy Rating from Citigroup Inc. – The Cerbat Gem"},"content":{"rendered":"
\"\"
Stock Observer<\/font><\/a><\/font><\/td>
\"\"<\/div>
Puma Biotechnology<\/b> Inc (PBYI) Receives Buy Rating from Citigroup Inc.<\/b><\/a>
The Cerbat Gem<\/font><\/b><\/font>
Puma Biotechnology<\/b> logo Puma Biotechnology<\/b> Inc (NYSE:PBYI)'s stock had its buy rating reissued by investment analysts at Citigroup Inc. in a research report issued to clients and investors on Monday, May 22nd, MarketBeat Ratings reports. They ...<\/b><\/font>
Puma Biotechnology<\/b> Inc - Receive News & Ratings Daily<\/a>BBNS<\/nobr><\/font><\/font>
The Puma Biotechnology<\/b> Inc (PBYI) Major Shareholder Adage Capital Partners Gp, LL Sells 247260 Shares of Stock<\/a>BangaloreWeekly<\/nobr><\/font><\/font>
Puma Biotechnology Target of Unusually Large Options Trading ...<\/a>Sports Perspectives<\/nobr><\/font><\/font>
Transcript Daily<\/nobr><\/a> -Markets Daily<\/nobr><\/a> -Stock Observer<\/nobr><\/a><\/font>
all 60 news articles »<\/b><\/nobr><\/a><\/font><\/div>

<\/p><\/font><\/td><\/tr><\/table>

<\/p>

The rest is here:
Puma Biotechnology Inc (PBYI) Receives Buy Rating from Citigroup Inc. - The Cerbat Gem<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Stock Observer Puma Biotechnology Inc (PBYI) Receives Buy Rating from Citigroup Inc. The Cerbat Gem Puma Biotechnology logo Puma Biotechnology Inc (NYSE:PBYI)'s stock had its buy rating reissued by investment analysts at Citigroup Inc. in a research report issued to clients and investors on Monday, May 22nd, MarketBeat Ratings reports. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-132955","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/132955"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=132955"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/132955\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=132955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=132955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=132955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}